Market revenue in 2023 | USD 113.1 million |
Market revenue in 2030 | USD 210.0 million |
Growth rate | 9.2% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.12% in 2023. Horizon Databook has segmented the India implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
The burden of several CVDs, including arrhythmias and SCAs, in India, is rising. The Longitudinal Ageing Study in India (LASI) revealed an increasing prevalence of CVDs with age. From 2017 to 2018, the self-reported prevalence of CVDs among adults aged 45–59 was 21.9%, which increased to 33.8% for those aged 60–74 and rose to 37.4% among individuals over 75.
This rising trend in disease prevalence, especially in the elderly population, is expected to drive the growth in the India ICD market. The demand for ICD devices will play a crucial role in diagnosing and managing cardiovascular conditions, addressing the healthcare needs of the aging population in India.
Moreover, the growing burden of cardiac disease is increasing the need for developing advanced products and technological innovations in heart failure & CVD management. This emphasis on technological innovation is anticipated to drive the adoption of CVD treatment in the coming years.
Horizon Databook provides a detailed overview of country-level data and insights on the India implantable cardioverter defibrillators market , including forecasts for subscribers. This country databook contains high-level insights into India implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account